Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Antonios Douros MD, PhD

Antonios Douros MD, PhD

Associate Professor of Pharmacoepidemiology, Institute of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin, Berlin, Germany

Dr. Antonios Douros received his medical and doctorate degrees and was trained in Clinical Pharmacology at Charité – Universitätsmedizin Berlin. He then completed a post-doctoral fellowship in Pharmacoepidemiology and worked as an Assistant Professor at McGill University. Since 2023, he is an Associate Professor at the Charité Institute of Clinical Pharmacology and Toxicology.

Dr. Douros studies the real-world effectiveness and safety of medications in vulnerable populations, including patients with liver disease, older adults, as well as patients subjected to polypharmacy and at risk of drug-drug interactions. For his studies, he uses large electronic healthcare databases from Canada, the United Kingdom, and Germany. He has (co-)authored >70 peer-reviewed publications including several in high-impact journals. His research is supported by awards and grants from the German Research Foundation, the Canadian Institutes of Health Research, and the Fonds de recherche du Québec - Santé.


Dr. Douros has no relevant disclosures.